Your browser doesn't support javascript.
loading
Dramatic regression of persistent tunica vasculosa lentis associated with retinopathy of prematurity following treatment with intravitreal bevacizumab.
Goldman, Darin R; Baumal, Caroline R.
Affiliation
  • Goldman DR; Department of Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, MA 02111, USA.
J Pediatr Ophthalmol Strabismus ; 50 Online: e27-9, 2013 Jun 04.
Article in En | MEDLINE | ID: mdl-23739589
ABSTRACT
The authors describe a preterm infant who developed advanced retinopathy of prematurity bilaterally with a prominent tunica vasculosa lentis. Treatment with intravitreal bevacizumab resulted in regression of the tunica vasculosa lentis and posterior manifestations of the retinopathy of prematurity. RetCam imaging (Clarity Medical Systems, Pleasanton, CA) of the anterior segment was used to document the dramatic tunica vasculosa lentis resolution.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinopathy of Prematurity / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized / Lens, Crystalline / Lens Diseases Type of study: Risk_factors_studies Limits: Humans / Male / Newborn Language: En Journal: J Pediatr Ophthalmol Strabismus Year: 2013 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinopathy of Prematurity / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized / Lens, Crystalline / Lens Diseases Type of study: Risk_factors_studies Limits: Humans / Male / Newborn Language: En Journal: J Pediatr Ophthalmol Strabismus Year: 2013 Document type: Article